Search Results 41-50 of 17002 for ibs
Myth or Matter-of-Fact: Inflammatory bowel disease and irritable bowel syndrome are both conditions from which full recovery is possible. Miss the show? Here's ...
Irritable bowel syndrome (IBS) is not a disease but a group of symptoms that affects 10 to 20 percent of the population in developed countries. IBS is also ...
This study will evaluate obesity as a comorbidity in a population of patients with irritable bowel syndrome (IBS), and assess this cohort for vitamin D- ...
Eluxadoline has been approved by the FDA for people with IBS-D but it is not known whether it will work the same way in people with IBS-D who also have BAM.
Studies have demonstrated that BAM occurs in about one-third of patients diagnosed with irritable bowel syndrome with diarrhea (IBS ... IBS-D. A clinical ...
This longitudinal study is being done to understand mechanisms underlying development of irritable bowel syndrome (IBS) and the role of the gut bacteria in ...
About this study. Microbiota from fecal samples from IBS-D patients, in combination with vitamin D supplementation added to our 3-D immunocompetent ...
This highly prevalent category of GI disorders includes irritable bowel syndrome (IBS), functional dyspepsia (FD) and centrally mediated abdominal pain syndrome ...
Clinical Trials · Reducing Intestinal Permeability with Hemp Hull WFI in IBS-Diarrhea With Evidence of Bile Acid Diarrhea · More about research at Mayo Clinic.
Dr. Saito Loftus' Irritable Bowel Syndrome Lab at Mayo Clinic studies epidemiology and genetic, environmental and familial contributors to GI disorders.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation can make a difference in the future of healthcare. Give now to support Mayo Clinic's research.